MedPath

Serum Biomarkers Associated With Postpartum T2DM in Women With GDM

Completed
Conditions
Gestational Diabetes
Registration Number
NCT04539288
Lead Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Brief Summary

Gestational diabetes mellitus (GDM) is commonly linked to the development of type 2 diabetes mellitus (T2DM). There is a need to characterize metabolic changes associated with GDM in order to find novel biomarkers for T2DM.

Detailed Description

GDM, a common complication of pregnancy, affects 17.8% of pregnancies worldwide per year. Women with a history of GDM have an approximately 7-fold higher risk for developing T2DM in the future than women without GDM. However, data on the factors associated with the development of T2DM in women with GDM are not widely available.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
3099
Inclusion Criteria
  • Women who were dignosed GDM.
  • Women with singleton pregnancy.
  • Give birth in the First Affiliated Hospital in Sun Yat-sen University.
Exclusion Criteria
  • Women who were diagnosed PGDM.
  • Younger than 18 years old.
  • Older than 45 years old.
  • Multiple pregnancy.
  • Diagnosed DM before.
  • Complicationg other diseases, like hypertension, thyroid diseases, etc.
  • Taking any drug affect glucose and lipid metabolism.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
T2DM4-6 weeks.

Women with GDM develop T2DM in postpartum.

Secondary Outcome Measures
NameTimeMethod
IGT4-6 weeks.

Women with GDM were impaired glucose intolerance in postpartum.

Trial Locations

Locations (1)

Obstetrics and Gynechology Department of the 1st affiliated hospital of Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath